Mankind Pharma outpaces Nifty Pharma 0.6% gain
Key Highlights
Mankind Pharma share price rose 5.20% to ₹2,432.20 at 09:19 IST on 27 October 2026. The company reported a net profit of ₹716 crore for Q2 FY27.
- Mankind Pharma rose 5.20% to ₹2,432.20 at 09:19 IST on 27 Oct 2026.
- so far was 0.69× its 20-session average.
- Q2 FY27 net profit: ₹716 crore, +37.67% on a year earlier.
- Nifty Pharma was +0.60%.
Figures as of: 09:19 IST, Tuesday 27 October 2026
Mankind Pharma Ltd. (MANKIND) shares rose 5.20% to ₹2,432.20 at 09:19 IST on Tuesday 27 October 2026. The trading volume reached 0.69× the 20-session average. The company filed its Q2 FY27 results on 26 October 2026, and the stock traded higher on 27 October 2026. The reported net profit for the quarter was ₹716 crore.
Mankind Pharma share price today
| Price (09:19 IST) | ₹2,432.20 |
| Change from the previous close (₹2,312.00) | +₹120.20 (+5.20%) |
| Day’s range | ₹2,352.10 – ₹2,436.10 |
| Volume so far | 4.5 lakh shares |
| 20-session average daily volume | 6.5 lakh shares (volume so far is 0.69× that) |
| Closing prices of the previous 4 sessions | ₹2,212.60 – ₹2,312.00 |
| 52-week range (adjusted prices) | ₹1,909.70 – ₹2,642.00 |
| Price against that range | 7.9% below the high, 27.4% above the low |
| Market value at this price | ₹1.00 lakh crore |
The stock traded within a range of ₹2,352.10 to ₹2,436.10 during the session. Trading volume reached 4.5 lakh shares, which is 0.69× the 20-session average daily volume. The current price of ₹2,432.20 sits 27.4% above the 52-week low of ₹1,909.70.
What has been announced
| When (IST) | Filing |
|---|---|
| Mon 26 Oct, 3:28 pm | Announcement under Regulation 30 (LODR)-Investor Presentation |
| Mon 26 Oct, 3:26 pm | Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Mon 26 Oct, 3:24 pm | Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
| Mon 26 Oct, 3:21 pm | Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
| Mon 26 Oct, 3:17 pm | Compliances-Reg. 54 – Asset Cover details |
| Mon 26 Oct, 3:14 pm | Board Meeting Outcome for Results For The Quarter And Half Year Ended 30Th September 2026 |
| Mon 26 Oct, 3:11 pm | Results For The Quarter And Half Year Ended 30Th September 2026 |
Q2 FY27 results at a glance
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Q1 FY27 | Change |
|---|---|---|---|---|---|
| from operations | 4,338 | 3,697 | +17.33% | 4,031 | +7.62% |
| 929 | 624 | +48.89% | 769 | +20.75% | |
| Net profit | 716 | 520 | +37.67% | 574 | +24.74% |
| Net profit as a share of revenue | 16.51% | 14.07% | – | 14.24% | – |
Mankind Pharma Ltd. (MANKIND) reported revenue from operations of ₹4,338 crore for Q2 FY27. The net profit of ₹716 crore represents a 37.67% increase compared to the same quarter a year earlier. For the first six months of the financial year, the company recorded a net profit of ₹1,290 crore.
How Mankind Pharma compares with its sector
| Change today | |
|---|---|
| Mankind Pharma | +5.20% |
| Nifty Pharma | +0.60% |
| −0.41% | |
| Gland Pharma | +2.16% |
| Ajanta Pharma | +1.61% |
| Sai Life Sciences | +1.14% |
| Aurobindo Pharma | +0.99% |
The Nifty Pharma index gained 0.60% during the session, while the Nifty 50 index was −0.41%. Among peers, Gland Pharma rose 2.16% and Ajanta Pharma gained 1.61%. Mankind Pharma Ltd. (MANKIND) recorded a price increase of 5.20% at the time of the reading.
Mankind Pharma share price: FAQs
What is the Mankind Pharma share price today?
₹2,432.20 at 09:19 IST on Tuesday 27 October 2026, up ₹120.20 or 5.20% from the previous close of ₹2,312.00.
What were Mankind Pharma’s Q2 FY27 results?
revenue from operations of ₹4,338 crore (+17.33% year on year) and net profit of ₹716 crore (+37.67%), for the quarter ended 30 September 2026.
When did Mankind Pharma announce the results?
The board meeting outcome was filed on Mon 26 Oct, 3:14 pm IST.
How is the Pharma sector doing today?
Nifty Pharma was +0.60% at 09:19 IST on Tuesday 27 October 2026, against +5.20% for Mankind Pharma.
This article is for information only and is not investment advice. Prices are from the National Stock Exchange, filings from BSE announcements and results from the company’s reported figures. Calculations are by ThePip. Prices and figures move through the session; the time above says when these were read. Investments in securities are subject to market risks.